Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Qeepl has opened a round of investment raising

6/28/24 OTCI

Shareholders of Surgutneftegaz approved dividends for 2023

6/28/24 SNGS

Shareholders of Gazprom Neft approved dividends for 2023

6/28/24 SIBN

Congo offered Lukoil new projects

6/28/24 LKOH

Etalon Group commissioned Domino Premium Residential Complex

6/28/24 ETLN

Pyatyorochka started work in the Jewish Autonomous Region

6/28/24 X5

Lenta will open mini-darkstores in 45 hypermarkets

6/28/24 LENT

VTB reported lower profits in May

6/28/24 VTBR

Shareholders of INARCTICA approved dividends for 3 months 2024

6/28/24 AQUA

Shareholders of INARCTICA approved dividends for 2023

6/28/24 AQUA